Relative contribution of Prevotella intermedia and Pseudomonas aeruginosa to lung pathology in airways of patients with cystic fibrosis
Open Access
Abstract
Background Patients with cystic fibrosis (CF) with Pseudomonas aeruginosa lung infections produce endobronchial mucus plugs allowing growth of obligate anaerobes including Prevotella spp. Whether obligate anaerobes contribute to the pathophysiology of CF lung disease is unknown. Methods The virulence of Prevotella intermedia and Ps aeruginosa was investigated in vitro and in mice, antibodies against P intermedia in CF sera were assessed and a culture-independent detection method for P intermedia/P nigrescens in CF sputum was tested. Results P intermedia reached cell numbers of >105–>107 colony-forming units (CFU)/ml sputum. The majority of patients with CF (16/17; 94.1%) produced antibodies against two immunoreactive antigens of P intermedia. Culture supernatant fluids, collected from 109 P intermedia cells, were more cytotoxic to respiratory epithelial cells in vitro and inflammatory in mouse lungs than respective fluids from anaerobically grown Ps aeruginosa, while fluids from aerobically grown Ps aeruginosa had the highest cytotoxicity and inflammation. Both pathological effects were largely reduced when culture supernatant fluids from 107 cells of either species were used. P intermedia cells (∼106CFU/lung) did not induce mortality in the agar beads lung infection mouse model, while Ps aeruginosa cells caused death in 30% of mice due to rapid multiplication. A P intermedia/P nigrescens-specific PNA probe was significantly more sensitive than culture-dependent diagnostic assays to detect these strict anaerobes. Conclusion Ps aeruginosa and P intermedia become significantly virulent in vitro and in vivo when cell numbers exceed 108 CFU/lung.Keywords
This publication has 33 references indexed in Scilit:
- Molecular Detection of Multiple Emerging Pathogens in Sputa from Cystic Fibrosis PatientsPLOS ONE, 2008
- Molecular identification of bacteria in bronchoalveolar lavage fluid from children with cystic fibrosisProceedings of the National Academy of Sciences, 2007
- Diagnostic value of serum antibodies in early Pseudomonas aeruginosa infection in cystic fibrosis patientsPediatric Pulmonology, 2007
- A physical linkage between cystic fibrosis airway surface dehydration and Pseudomonas aeruginosa biofilmsProceedings of the National Academy of Sciences, 2006
- Use of 16S rRNA Gene Profiling by Terminal Restriction Fragment Length Polymorphism Analysis To Compare Bacterial Communities in Sputum and Mouthwash Samples from Patients with Cystic FibrosisJournal of Clinical Microbiology, 2006
- Genetic adaptation by Pseudomonas aeruginosa to the airways of cystic fibrosis patientsProceedings of the National Academy of Sciences, 2006
- NonmucoidPseudomonas aeruginosaExpresses Alginate in the Lungs of Patients with Cystic Fibrosis and in a Mouse ModelThe Journal of Infectious Diseases, 2005
- Bacterial Diversity in Cases of Lung Infection in Cystic Fibrosis Patients: 16S Ribosomal DNA (rDNA) Length Heterogeneity PCR and 16S rDNA Terminal Restriction Fragment Length Polymorphism ProfilingJournal of Clinical Microbiology, 2003
- Characterization of intact microorganisms by MALDI mass spectrometryMass Spectrometry Reviews, 2001
- A study of the use of ultrasonically nebulized lignocaine for local anaesthesia during fibreoptic bronchoscopyRespiratory Medicine, 1985